|
Volumn 6, Issue 5, 2010, Pages 251-253
|
Growth and development: How safe is growth hormone therapy for children?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT GROWTH HORMONE;
SOMATOMEDIN C;
ADRENAL INSUFFICIENCY;
AVASCULAR NECROSIS;
BONE DISEASE;
BREAST CANCER;
CANCER RISK;
CANCER SURVIVOR;
CARCINOGENICITY;
CHILD;
CHILDHOOD CANCER;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SAFETY;
GROWTH HORMONE DEFICIENCY;
HORMONAL THERAPY;
HUMAN;
HYPOPHYSIS DISEASE;
HYPOPITUITARISM;
IN VITRO STUDY;
JAPANESE;
LEUKEMIA;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK FACTOR;
SCOLIOSIS;
SHORT STATURE;
SHORT SURVEY;
SLIPPED CAPITAL FEMORAL EPIPHYSIS;
CHILD;
FEMALE;
GROWTH DISORDERS;
HUMAN GROWTH HORMONE;
HUMANS;
MALE;
NEOPLASMS;
RISK FACTORS;
|
EID: 77951698107
PISSN: 17595029
EISSN: 17595037
Source Type: Journal
DOI: 10.1038/nrendo.2010.43 Document Type: Short Survey |
Times cited : (4)
|
References (8)
|